| Trade Date |
Insider |
Title |
Buy or Sell |
Quantity |
Security Type |
Price |
Proceeds |
Transaction Conviction |
Position Quantity |
Position Value |
Positon Conviction |
SEC Link |
Nature of Ownership |
2020-07-01 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 10,795,348 | $0.00 | - | Form 4 | Footnote | 2020-07-01 | Partners, L.p. Broadwood | - | Sell | 4,062 | Common Stock | $0.00 | $0.00 | - | 10,795,348 | $0.00 | - | Form 4 | - | 2020-05-15 | Keith Holliday | Chief Technology Officer | Buy | 25,000 | Common Stock | $7.20 | -$180,000.00 | 5.49 [ Very High ] | 53,447 | $384,818.40 | 11.74 [Average] | Form 4 | - | 2020-05-15 | Keith Holliday | Chief Technology Officer | Sell | 25,000 | Common Stock | $37.69 | $942,250.00 | 5.49 [ Very High ] | 28,447 | $1,072,167.43 | 6.25 [Average] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000 | Common Stock | $5.34 | -$106,800.00 | 4.39 [ Very High ] | 61,185 | $326,727.90 | 13.44 [Average] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000 | Common Stock | $7.35 | -$147,000.00 | 4.39 [ Very High ] | 81,185 | $596,709.75 | 17.84 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000 | Common Stock | $7.52 | -$150,400.00 | 4.39 [ Very High ] | 101,185 | $760,911.20 | 22.23 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 21,875 | Common Stock | $9.30 | -$203,437.50 | 4.81 [ Very High ] | 123,060 | $1,144,458.00 | 27.04 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 50,000 | Common Stock | $11.02 | -$551,000.00 | 10.99 [ Very High ] | 173,060 | $1,907,121.20 | 38.02 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000 | Common Stock | $11.02 | -$220,400.00 | 4.39 [ Very High ] | 193,060 | $2,127,521.20 | 42.42 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 12,500 | Common Stock | $15.54 | -$194,250.00 | 2.75 [ Very High ] | 205,560 | $3,194,402.40 | 45.16 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 13,333 | Common Stock | $16.50 | -$219,994.50 | 2.93 [ Very High ] | 218,893 | $3,611,734.50 | 48.09 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 6,292 | Common Stock | $29.80 | -$187,501.60 | 1.38 [ High ] | 225,185 | $6,710,513.00 | 49.47 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 8,522 | Common Stock | $35.98 | -$306,621.56 | 1.87 [ High ] | 233,707 | $8,408,777.86 | 51.35 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Sell | 192,522 | Common Stock | $40.00 | $7,700,880.00 | 42.30 [ Very High ] | 41,185 | $1,647,400.00 | 9.05 [Average] | Form 4 | - | 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 8,000 | Common Stock | $7.35 | -$58,800.00 | 1.76 [ High ] | 52,466 | $385,625.10 | 11.53 [Average] | Form 4 | - | 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 10,856 | Common Stock | $15.54 | -$168,702.24 | 2.39 [ Very High ] | 63,322 | $984,023.88 | 13.91 [Average] | Form 4 | - | 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 18,856 | Common Stock | $39.06 | $736,515.36 | 4.14 [ Very High ] | 44,466 | $1,736,841.96 | 9.77 [Average] | Form 4 | - | 2020-05-13 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 6,667 | Common Stock | $5.34 | -$35,601.78 | 1.46 [ High ] | 51,133 | $273,050.22 | 11.23 [Average] | Form 4 | - | 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 21,294 | Common Stock | $9.30 | -$198,034.20 | 4.68 [ Very High ] | 32,088 | $298,418.40 | 7.05 [Average] | Form 4 | - | 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 19,178 | Common Stock | $7.52 | -$144,218.56 | 4.21 [ Very High ] | 51,266 | $385,520.32 | 11.26 [Average] | Form 4 | - | 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 6,091 | Common Stock | $8.64 | -$52,626.24 | 1.34 [ High ] | 57,357 | $495,564.48 | 12.60 [Average] | Form 4 | - | 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 46,563 | Common Stock | $39.11 | $1,821,078.93 | 10.23 [ Very High ] | 10,794 | $422,153.34 | 2.37 [Low] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 3,437 | Common Stock | $39.02 | $134,111.74 | 0.76 [ High ] | 16,022 | $625,178.44 | 3.52 [Low] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 6,741 | Common Stock | $9.30 | -$62,691.30 | 1.48 [ High ] | 22,763 | $211,695.90 | 5.00 [Average] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 2,860 | Common Stock | $39.04 | $111,654.40 | 0.63 [ Average ] | 19,903 | $777,013.12 | 4.37 [Low] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 4,862 | Common Stock | $15.25 | -$74,145.50 | 1.07 [ High ] | 24,765 | $377,666.25 | 5.44 [Average] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 3,473 | Common Stock | $39.02 | $135,516.46 | 0.76 [ High ] | 21,292 | $830,813.84 | 4.68 [Average] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 8,680 | Common Stock | $16.15 | -$140,182.00 | 1.91 [ High ] | 29,972 | $484,047.80 | 6.59 [Average] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 8,419 | Common Stock | $39.01 | $328,425.19 | 1.85 [ High ] | 21,553 | $840,782.53 | 4.74 [Average] | Form 4 | - | 2020-06-01 | Gilbert H Kliman | - | Buy | 464 | Common Stock | $0.00 | $0.00 | - | 464 | $0.00 | - | Form 4 | - | 2020-06-10 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 785 | Common Stock | $11.00 | -$8,635.00 | - | 128,735 | $1,416,085.00 | - | Form 4 | - | 2020-06-10 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 785 | Common Stock | $44.00 | $34,540.00 | - | 127,950 | $5,629,800.00 | - | Form 4 | - | 2020-06-15 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 19,215 | Common Stock | $11.00 | -$211,365.00 | - | 147,165 | $1,618,815.00 | - | Form 4 | - | 2020-06-15 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 20,000 | Common Stock | $5.34 | -$106,800.00 | - | 167,165 | $892,661.10 | - | Form 4 | - | 2020-06-15 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 39,215 | Common Stock | $44.07 | $1,728,205.05 | - | 127,950 | $5,638,756.50 | - | Form 4 | - | 2020-07-30 | Stephen C Farrell | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 5,808 | $0.00 | 1.28 [Low] | Form 4 | - | 2020-07-30 | Lou Silverman | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 15,850 | $0.00 | 3.48 [Low] | Form 4 | - | 2020-07-30 | Gilbert H Kliman | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 2,581 | $0.00 | 0.57 [Very Low] | Form 4 | - | 2020-07-30 | John C Moore | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 2,117 | $0.00 | 0.47 [Very Low] | Form 4 | - | 2020-07-30 | Thomas G Frinzi | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 2,117 | $0.00 | 0.47 [Very Low] | Form 4 | - | 2020-08-10 | Patrick F. Williams | Chief Financial Officer | Buy | 30,727 | Common Stock | $0.00 | $0.00 | - | 30,727 | $0.00 | 6.71 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 16,206 | Common Stock | $9.30 | -$150,715.80 | 3.54 [ Very High ] | 27,000 | $251,100.00 | 5.89 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 5,822 | Common Stock | $7.52 | -$43,781.44 | 1.27 [ High ] | 32,822 | $246,821.44 | 7.17 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 11,574 | Common Stock | $8.64 | -$99,999.36 | 2.53 [ Very High ] | 44,396 | $383,581.44 | 9.69 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 8,000 | Common Stock | $16.15 | -$129,200.00 | 1.75 [ High ] | 52,396 | $846,195.40 | 11.44 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 41,602 | Common Stock | $51.22 | $2,130,854.44 | 9.08 [ Very High ] | 10,794 | $552,868.68 | 2.36 [Low] | Form 4 | - | 2020-09-09 | John C Moore | - | Sell | 137,331 | Common Stock | $52.04 | $7,146,705.24 | 29.98 [ Very High ] | 21,387 | $1,112,979.48 | 4.67 [Low] | Form 4 | By Family Trust | 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 1,286 | Common Stock | $7.52 | -$9,670.72 | 0.28 [ Low ] | 29,733 | $223,592.16 | 6.49 [Average] | Form 4 | - | 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 21,294 | Common Stock | $9.30 | -$198,034.20 | 4.65 [ Very High ] | 51,027 | $474,551.10 | 11.14 [Average] | Form 4 | - | 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 3,994 | Common Stock | $16.15 | -$64,503.10 | 0.87 [ High ] | 55,021 | $888,589.15 | 12.01 [Average] | Form 4 | - | 2020-09-14 | Keith Holliday | Chief Technology Officer | Sell | 26,574 | Common Stock | $53.26 | $1,415,331.24 | 5.80 [ Very High ] | 28,447 | $1,515,087.22 | 6.21 [Average] | Form 4 | - | 2020-09-14 | Keith Holliday | Chief Technology Officer | Sell | 9,115 | Common Stock | $53.49 | $487,561.35 | 1.99 [ High ] | 19,332 | $1,034,068.68 | 4.22 [Low] | Form 4 | - | 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 13,217 | Common Stock | $16.15 | -$213,454.55 | 2.89 [ Very High ] | 32,549 | $525,666.35 | 7.11 [Average] | Form 4 | - | 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 10,112 | Common Stock | $29.80 | -$301,337.60 | 2.21 [ High ] | 42,661 | $1,271,297.80 | 9.31 [Average] | Form 4 | - | 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 12,997 | Common Stock | $35.98 | -$467,632.06 | 2.84 [ Very High ] | 55,658 | $2,002,574.84 | 12.15 [Average] | Form 4 | - | 2020-09-15 | Keith Holliday | Chief Technology Officer | Sell | 36,326 | Common Stock | $53.33 | $1,937,265.58 | 7.93 [ Very High ] | 19,332 | $1,030,975.56 | 4.22 [Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Buy | 5,000 | Common Stock | $10.31 | -$51,550.00 | 1.08 [ High ] | 7,117 | $73,376.27 | 1.54 [Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Buy | 10,000 | Common Stock | $15.73 | -$157,300.00 | 2.17 [ High ] | 17,117 | $269,250.41 | 3.71 [Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Buy | 1,206 | Common Stock | $16.15 | -$19,476.90 | 0.26 [ Low ] | 18,323 | $295,916.45 | 3.97 [Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Sell | 16,206 | Common Stock | $81.03 | $1,313,172.18 | 3.51 [ Very High ] | 2,117 | $171,540.51 | 0.46 [Very Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Sell | 14,254 | Common Stock | $80.88 | $1,152,863.52 | 3.09 [ Very High ] | 11,387 | $920,980.56 | 2.47 [Low] | Form 4 | By Family Trust | 2020-11-09 | Keith Holliday | Chief Technology Officer | Buy | 23,714 | Common Stock | $7.52 | -$178,329.28 | 5.14 [ Very High ] | 43,046 | $323,705.92 | 9.34 [Average] | Form 4 | - | 2020-11-09 | Keith Holliday | Chief Technology Officer | Buy | 15,000 | Common Stock | $9.30 | -$139,500.00 | 3.25 [ Very High ] | 58,046 | $539,827.80 | 12.59 [Average] | Form 4 | - | 2020-11-09 | Keith Holliday | Chief Technology Officer | Sell | 23,714 | Common Stock | $81.56 | $1,934,113.84 | 5.14 [ Very High ] | 34,332 | $2,800,117.92 | 7.45 [Average] | Form 4 | - | 2020-11-09 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 10,200 | Common Stock | $29.80 | -$303,960.00 | 2.21 [ High ] | 20,994 | $625,621.20 | 4.55 [Low] | Form 4 | - | 2020-11-09 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 9,800 | Common Stock | $16.15 | -$158,270.00 | 2.13 [ High ] | 30,794 | $497,323.10 | 6.68 [Average] | Form 4 | - | 2020-11-09 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 20,000 | Common Stock | $81.34 | $1,626,800.00 | 4.34 [ Very High ] | 10,794 | $877,983.96 | 2.34 [Low] | Form 4 | - | 2020-11-16 | Scott D Barnes | Chief Medical Officer | Buy | 5,430 | Common Stock | $29.80 | -$161,814.00 | 1.18 [ High ] | 25,820 | $769,436.00 | 5.60 [Average] | Form 4 | - | 2020-11-16 | Scott D Barnes | Chief Medical Officer | Buy | 17,163 | Common Stock | $35.98 | -$617,524.74 | 3.72 [ Very High ] | 42,983 | $1,546,528.34 | 9.32 [Average] | Form 4 | - | 2020-11-16 | Scott D Barnes | Chief Medical Officer | Sell | 22,593 | Common Stock | $80.25 | $1,813,088.25 | 4.90 [ Very High ] | 20,390 | $1,636,297.50 | 4.42 [Low] | Form 4 | - | 2020-11-19 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 12,156 | Common Stock | $15.54 | -$188,904.24 | 2.64 [ Very High ] | 140,106 | $2,177,247.24 | 30.39 [High] | Form 4 | - | 2020-11-19 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 12,156 | Common Stock | $82.02 | $997,035.12 | 2.64 [ Very High ] | 127,950 | $10,494,459.00 | 27.75 [High] | Form 4 | - | 2020-11-19 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 14,007 | Common Stock | $82.03 | $1,148,994.21 | 3.04 [ Very High ] | 113,943 | $9,346,744.29 | 24.71 [High] | Form 4 | - | 2020-11-20 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 2,688 | Common Stock | $83.02 | $223,157.76 | 0.58 [ Average ] | 111,255 | $9,236,390.10 | 24.13 [High] | Form 4 | - | 2020-11-23 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 1,900 | Common Stock | $15.54 | -$29,526.00 | 0.41 [ Average ] | 113,155 | $1,758,428.70 | 24.54 [High] | Form 4 | - | 2020-11-23 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 1,900 | Common Stock | $83.02 | $157,738.00 | 0.41 [ Average ] | 111,255 | $9,236,390.10 | 24.13 [High] | Form 4 | - | 2020-11-23 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 2,874 | Common Stock | $83.14 | $238,944.36 | 0.62 [ Average ] | 108,381 | $9,010,796.34 | 23.50 [High] | Form 4 | - | 2020-11-23 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 14,815 | Common Stock | $7.35 | -$108,890.25 | 3.21 [ Very High ] | 66,198 | $486,555.30 | 14.36 [Average] | Form 4 | - | 2020-11-23 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 4,144 | Common Stock | $15.54 | -$64,397.76 | 0.90 [ High ] | 70,342 | $1,093,114.68 | 15.26 [Average] | Form 4 | - | 2020-11-23 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 18,959 | Common Stock | $80.13 | $1,519,184.67 | 4.11 [ Very High ] | 51,383 | $4,117,319.79 | 11.14 [Average] | Form 4 | - | 2021-01-04 | Partners, L.p. Broadwood | - | Sell | 45,443 | Common Stock | $0.00 | $0.00 | - | 10,749,905 | $0.00 | 2,331.36 [Very High] | Form 4 | - | 2021-01-04 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 10,749,905 | $0.00 | 2,331.36 [Very High] | Form 4 | Footnote | 2021-01-12 | Partners, L.p. Broadwood | - | Sell | 60,000 | Common Stock | $89.28 | $5,356,800.00 | 13.01 [ Very High ] | 10,689,905 | $954,394,718.40 | 2,318.35 [Very High] | Form 4 | - | 2021-01-12 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 10,689,905 | $0.00 | 2,318.35 [Very High] | Form 4 | Footnote |
